ADVENT CAPITAL MANAGEMENT /DE/

13F Filings History

Latest 13F report
Q4 2024 - Feb 13, 2025
Value $
$4.31B
Signature - Title
Paul L Latronica - Managing Director and Portfolio Manager
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by ADVENT CAPITAL MANAGEMENT /DE/. Form 13F is required to be filed within 45 days of the end of a calendar quarter. ADVENT CAPITAL MANAGEMENT /DE/ reported 187 stock holdings with total value $4.31B as of Q4 2024. Top holdings included BACPRL, WFCPRL, APOPRA, BAPRA, and NEEPRR.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q4 2024 187 $4.31B +$1.3B -$1.01B +$289M BACPRL, WFCPRL, APOPRA, BAPRA, NEEPRR 13F-HR 2/13/2025, 04:58 PM
Q3 2024 196 $4.01B +$898M -$1.14B -$246M BACPRL, WFCPRL, APOPRA, NEEPRR, HPEPRC 13F-HR 11/13/2024, 02:01 PM
Q2 2024 179 $4.11B +$1.28B -$1.07B +$216M BACPRL, WFCPRL, APOPRA, NEEPRR, ALBPRA 13F-HR 8/13/2024, 01:05 PM
Q1 2024 166 $3.93B +$538M -$1.06B -$519M WFCPRL, BACPRL, NEEPRR, APOPRA, GTLSPRB 13F-HR 5/14/2024, 03:37 PM
Q4 2023 183 $4.36B +$964M -$1.08B -$112M WFCPRL, BACPRL, NEEPRR, APOPRA, GTLSPRB 13F-HR 2/13/2024, 03:31 PM
Q3 2023 268 $4.22B +$775M -$1.54B -$768M BACPRL, WFCPRL, APOPRA, GTLSPRB, SPY 13F-HR 11/13/2023, 04:52 PM
Q2 2023 228 $5.17B +$1.5B -$710M +$791M BACPRL, WFCPRL, KKRPRC, NEEPRQ, NIMC 13F-HR 8/11/2023, 02:40 PM
Q1 2023 216 $5.29B +$726M -$930M -$204M BACPRL, WFCPRL, NEEPRQ, NIMC, KKRPRC 13F-HR 5/12/2023, 04:12 PM
Q4 2022 248 $5.76B +$1.64B -$704M +$935M BACPRL, WFCPRL, SPY, SPY, NIMC 13F-HR 2/14/2023, 09:04 AM
Q3 2022 228 $5.52B +$964M -$613M +$350M BACPRL, WFCPRL, NEEPRQ, KKRPRC, SPY Restatement 11/14/2022, 08:31 PM
Q2 2022 245 $5.65B +$1.13B -$508M +$620M BACPRL, WFCPRL, NEEPRQ, KKRPRC, NIMC 13F-HR 8/15/2022, 12:09 PM
Q1 2022 274 $6.25B +$1.7B -$667M +$1.03B BACPRL, WFCPRL, KKRPRC, NEEPRQ, SWT 13F-HR 5/13/2022, 03:13 PM
Q4 2021 284 $5.95B +$1.61B -$946M +$663M BACPRL, WFCPRL, KKRPRC, SWT, AVGOP 13F-HR 2/14/2022, 11:12 AM
Q3 2021 262 $5.41B +$1.14B -$832M +$311M SWT, NEEPRQ, AEPPZ, NIMC, NEEPRP 13F-HR 11/15/2021, 12:18 PM
Q2 2021 252 $5.14B +$1.56B -$1.09B +$480M SWT, NEEPRQ, AEPPZ, NIMC, DCUE 13F-HR 8/16/2021, 01:01 PM
Q1 2021 245 $4.64B +$927M -$1.06B -$133M SWT, NEEPRQ, DCUE, AEPPZ, NEEPRP 13F-HR 5/17/2021, 02:59 PM
Q4 2020 199 $4.69B +$894M -$707M +$187M SWT, NEEPRQ, DCUE, NEEPRP, DTP 13F-HR 2/16/2021, 12:51 PM
Q3 2020 174 $4.53B +$706M -$576M +$130M BACPRL, WFCPRL, SWT, DCUE, NEEPRP 13F-HR 11/16/2020, 02:03 PM
Q2 2020 173 $4.27B +$515M -$848M -$333M BACPRL, WFCPRL, DCUE, SWT, NEEPRO 13F-HR 8/14/2020, 10:16 AM
Q1 2020 200 $4.6B +$940M -$571M +$369M BACPRL, WFCPRL, AVGOP, DCUE, NEEPRO 13F-HR 5/15/2020, 02:37 PM
Q4 2019 215 $5.16B +$568M -$795M -$227M BACPRL, WFCPRL, AVGOP, DCUE, SOLN 13F-HR 2/14/2020, 12:24 PM
Q3 2019 213 $5.34B +$1.06B -$724M +$341M WFCPRL, BACPRL, SOLN, DCUE, AEPPL 13F-HR 11/14/2019, 02:59 PM
Q2 2019 201 $5.17B +$1.21B -$523M +$685M WFCPRL, BACPRL, DCUE, NEEPRR, BDXA 13F-HR 8/14/2019, 03:30 PM
Q1 2019 212 $4.49B +$823M -$458M +$365M WFCPRL, BACPRL, NEEPRR, DHRPRA, SWP 13F-HR 5/15/2019, 12:52 PM
Q4 2018 242 $4.13B +$545M -$510M +$34.8M WFCPRL, BACPRL, NEEPRR, BDXA, SWP 13F-HR 2/14/2019, 03:09 PM
Q3 2018 317 $4.81B +$992M -$728M +$265M WFCPRL, BACPRL, SWP, BDXA, CCIPRA 13F-HR 11/14/2018, 04:17 PM
Q2 2018 276 $4.68B +$648M -$814M -$165M WFCPRL, BACPRL, SWP, NEEPRR, CCIPRA 13F-HR 8/14/2018, 01:32 PM
Q1 2018 271 $5.09B +$1.03B -$911M +$119M WFCPRL, BACPRL, SWP, BDXA, NEEPRR 13F-HR 5/11/2018, 01:43 PM
Q4 2017 258 $5.22B +$767M -$541M +$227M WFCPRL, BACPRL, BDXA, SWP, NEEPRR 13F-HR 2/13/2018, 11:29 AM
Q3 2017 289 $5.28B +$764M -$566M +$198M WFCPRL, BACPRL, BDXA, CCIPRA, AGNPRA 13F-HR 11/14/2017, 10:07 AM
Q2 2017 301 $5.23B +$697M -$671M +$26.1M WFCPRL, BACPRL, BDXA, AGNPRA, SWP 13F-HR 8/9/2017, 11:04 AM
Q1 2017 258 $5.35B +$580M -$703M -$123M WFCPRL, ANTX, BACPRL, NEEPRR, DCUD 13F-HR 5/5/2017, 10:33 AM
Q4 2016 305 $5.43B +$691M -$518M +$173M WFCPRL, ANTX, BACPRL, KEYPRG, FTRPR 13F-HR 2/13/2017, 11:24 AM
Q3 2016 495 $6.89B +$1.22B -$3.98B -$2.77B WFCPRL, AATRL, BACPRL, ANTX, AREPRD 13F-HR 11/22/2016, 09:35 AM
Q2 2016 458 $6.46B WFCPRL, AATRL, BACPRL, ANTX, FTRPR 13F-HR 8/5/2016, 01:06 PM
Q1 2016 422 $6.55B WFCPRL, AATRL, BACPRL, ANTX, AREPRD 13F-HR 5/13/2016, 01:50 PM
Q4 2015 443 $6.5B WFCPRL, AATRL, FTRPR, ANTX, BACPRL 13F-HR 2/16/2016, 08:30 AM
Q3 2015 475 $6.54B WFCPRL, AATRL, FTRPR, ANTX, BACPRL 13F-HR 11/13/2015, 11:53 AM
Q2 2015 487 $6.95B WFCPRL, AATRL, FTRPR, ANTX, BACPRL 13F-HR 7/24/2015, 02:02 PM
Q1 2015 457 $6.92B WFCPRL, AATRL, BACPRL, AREPRD, TYFDL 13F-HR 5/13/2015, 01:40 PM
Q4 2014 462 $6.8B WFCPRL, BACPRL, UTXPRA, TYFDL, AREPRD 13F-HR 2/26/2015, 11:00 AM
Q3 2014 458 $6.48B +$293M -$1.05B -$758M UTXPRA, BACPRL, WFCPRL, AREPRD, KEYPRG 13F-HR 11/14/2014, 12:03 PM
Q2 2014 457 $6.7B +$2.66B -$799M +$1.86B UTXPRA, BACPRL, WFCPRL, AREPRD, KEYPRG Restatement 9/25/2014, 03:17 PM
Q1 2014 444 $6.4B +$1.97B -$725M +$1.25B UTXPRA, MLU, BACPRL, WFCPRL, AREPRD 13F-HR 5/16/2014, 12:06 PM
Q4 2013 600 $7.94B WFCPRL, UTXPRA, AATRL, KEYPRG, BACPRL 13F-HR 2/11/2014, 09:38 AM